Jean‐Jacques Patard

Nissan (United Kingdom) — United Kingdom

Medicine · Health Sciences

55h-index12.3kcitations299works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal cell carcinoma treatment(227), Renal and related cancers(143), Bladder and Urothelial Cancer Treatments(78), Cancer Genomics and Diagnostics(52), Multiple and Secondary Primary Cancers(41)

Publications299 total

Local recurrence after R0 partial nephrectomy for RCC: insights from a large multicenter cohort (PREPARE study – UroCCR 140)
World Journal of Urology·2025
Clinical and pathological features associated with chromophobe renal cell carcinoma recurrence: analysis from a nationwide cohort (UroCCR-136)
European Urology Open Science·2025Open Access
Management of urinary fistulas after partial nephrectomy: results from the U-LEAK study (UroCCR-181)
2025Open Access
Value of the urine culture and antibiotic prophylaxis before partial nephrectomy in cancer (UroCCR n°107 - NephroBacte)
World Journal of Urology·2025
Investigation of whether renal tumours with caval thrombi induce particular risks: a multicentre study (UroCCR‐174 CAVORISK)
British Journal of Urology·2025· 1 citedOpen Access
PD36-03 OFF-CLAMP AND ON-CLAMP ROBOTIC-ASSISTED PARTIAL NEPHRECTOMY (RAPN) FOR ISCHEMIA-SENSITIVE PATIENTS: A PROPENSITY SCORE-MATCHED ANALYSIS (UROCCR 187).
The Journal of Urology·2025
Racial Disparities in Renal Cell Carcinoma Histology and Outcomes: Insights from the French Kidney Cancer Research Network (UroCCR-191)
SSRN Electronic Journal·2025Open Access
Étude des facteurs prédictifs de la récidive locale des cancers du rein après chirurgie par néphrectomie partielle en marge négative (R0)
Progrès en Urologie - FMC·2024
Oncologic surveillance after surgical treatment for clinically localized kidney cancer: UroCCR study n. 129
Minerva Urology and Nephrology·2024· 6 cited
Robot-assisted Partial Nephrectomy for Hilar and Nonhilar Renal Masses: Comparison of Perioperative, Oncological, and Functional Results in a Multicentre Prospective Cohort (NEPRAH Study, UroCCR 175)
European Urology Oncology·2024· 13 cited
Preparing for the Worst: Management and Predictive Factors of Open Conversion During Minimally Invasive Renal Tumor Surgery (UroCCR-135 Study)
European Urology Open Science·2024· 2 citedOpen Access
Late complications and 5 years outcomes of robotic partial nephrectomy in France: prospective assessment in the French Kidney Cancer Research Network (UroCCR 10)
World Journal of Urology·2023· 9 cited
Supplemental Figure 7-10 from Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting
2023Open Access
Supplementary Figure 1 from MET Is a Potential Target across All Papillary Renal Cell Carcinomas: Result from a Large Molecular Study of pRCC with CGH Array and Matching Gene Expression Array
2023Open Access
Supplementary Figure and Table Legends from Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting
2023Open Access
Supplemental Table 7-10 from Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting
2023Open Access
Supplemental Figure 1-3 from Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting
2023Open Access
Supplementary Figure and Table Legends from Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting
2023Open Access
Supplementary Figure 1 from MET Is a Potential Target across All Papillary Renal Cell Carcinomas: Result from a Large Molecular Study of pRCC with CGH Array and Matching Gene Expression Array
2023Open Access
Supplementary Figure 2 from MET Is a Potential Target across All Papillary Renal Cell Carcinomas: Result from a Large Molecular Study of pRCC with CGH Array and Matching Gene Expression Array
2023Open Access
page 1 of 15Next →

Frequent Co-authors

Jacques Tostain(21), Alexandre de la Taille(19), Luca Cindolo(15), Karim Bensalah(13), Arnaud Méjean(12), Walter Artibani(12), Richard Zigeuner(12), Jean‐Christophe Bernhard(11), F. Guillé(11), Allan J. Pantuck(10), Peter F.A. Mulders(9), Luigi Schips(9), Laurent Salomon(9), N. Costedoat‐Chalumeau(9), Hervé Lang(8), Bernard Lobel(8), Arie S. Belldegrun(8), Pierre I. Karakiewicz(8), Vincenzo Ficarra(8), Vincenzo Ficarra(7)